Insulin Invest Advisor

Pharmaceuticals
FDA Issues Complete Response Letter to Novo Nordisk for Icodec Insulin Jul 11, 2024
Pharmaceuticals
Groundbreaking INHALE-3 Study Validates Efficacy of Inhaled Insulin for Type 1 Diabetes Jun 23, 2024
Pharmaceuticals
INHALE-3 Study Highlights Superior Efficacy of Inhaled Insulin for T1D Management Jun 23, 2024